CN Patent
CN111836819A — 一种含有芳胺基取代的吡咯并嘧啶类化合物、制备方法及其应用
Assigned to Beijing Scitech MQ Pharmaceuticals Ltd · Expires 2020-10-27 · 6y expired
What this patent protects
本发明提供了一种含有芳胺基取代的吡咯并嘧啶类化合物、制备方法及其应用,具体涉及式(I)所示化合物、其异构体、水合物、溶剂化物、其药学上可接受的盐及其前药,其制备方法及其在制备作为激酶抑制剂的药物中的应用。
USPTO Abstract
本发明提供了一种含有芳胺基取代的吡咯并嘧啶类化合物、制备方法及其应用,具体涉及式(I)所示化合物、其异构体、水合物、溶剂化物、其药学上可接受的盐及其前药,其制备方法及其在制备作为激酶抑制剂的药物中的应用。
Drugs covered by this patent
- Alunbrig (brigatinib) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.